سرمایه گذاری شفا دارو

شفا | Stocks - Tehran Stock Exchange (TSE)

سایر محصولات دارویی

Sector:

Market Type:

Status:

Last Price: 80,330 0.30

Close Price: 81,110

	2026/05/10 Fiscal Year 2025/12/2112 Month	2025/04/20 Fiscal Year 2024/12/2012 Month	2024/05/26 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	94.63	94.8	97.66
Gross Profit to Sales	94.68	94.91	97.66
Operating Margin	92.37	91.72	92.82
Gross Profit to Sales	100	100	100
Net Profit to Gross Profit	94.63	94.8	97.66
Return on Assets (ROA)	22.71	16.04	22.16
Return on Capital (%)	210.01	118.66	148.86
Return on Equity (ROE)	36.41	27.88	36.17
Working Capital Return	47.09	41.18	53.59
Fixed Asset Return	24,759.34	1,453.57	11,868.23
Loan Benefit Assessment	1.6	1.74	1.63
Current Ratio	2.29	1.92	2.07
Quick Ratio	1.77	1.92	2.07
Liquidity Ratio	0.1	0.1	0.11
Net Working Capital	12,094,009	7,814,791	7,533,514
Current Assets Ratio	0.86	0.81	0.8
Receivables Collection Period	949.91	1,662.98	1,213.92
Inventory to Working Capital	0.4	-	-
Working Capital Turnover	0.5	0.43	0.55
Fixed Asset Turnover	261.65	15.33	121.53
Total Asset Turnover	0.24	0.17	0.23
Debt Ratio	0.38	0.42	0.39
Debt to Equity	0.6	0.74	0.63
Long-Term Debt to Equity	0	0	0
Current Debt to Equity	0.6	0.73	0.63
Equity Ratio	62.37	57.51	61.25
Debt Coverage Ratio	0.43	3.86	0.8

At a Glance